Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry

Completed

Conditions studied: Primary Brain Tumor

In brief

The NeuroBlate® System (NBS), is a minimally invasive robotic laser thermotherapy tool. It employs a pulsed surgical laser to deliver targeted energy to abnormal brain tissue caused by tumors and lesions. Since receiving FDA clearance in April 2013, the NBS has been used in nearly 300 procedures conducted at approximately 20 leading institutions across the United States. This post-market, multi-center retrospective study is designed to collect long-term follow-up data on patients who were treated previously with NBS.

Key facts

Study ID: NCT02389855
Run by: Monteris Medical
People needed: 144
Starts: 2015-02-01
Expected to finish: 2016-08-01
Last updated by the study team: 2024-04-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Patient was previously treated with NBS
Patient is willing and able to provide informed consent and authorization for release of personal health information or IRB waiver is granted to collect study information without patient consent
Exclusion Criteria: There are no exclusion criteria for this study.

Where it is running

Yale University — New Haven, Connecticut, United States
Kansas University Medical Center — Kansas City, Kansas, United States
St. Luke's Hospital — Kansas City, Missouri, United States
Washington University in St. Louis — St Louis, Missouri, United States
Wake Forest — Salem, North Carolina, United States
University Hospitals Cleveland Medical Center — Cleveland, Ohio, United States
Cleveland Clinic — Cleveland, Ohio, United States
Thomas Jefferson University — Philadelphia, Pennsylvania, United States
The University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.